A detailed history of Jones Financial Companies Lllp transactions in Incyte Corp stock. As of the latest transaction made, Jones Financial Companies Lllp holds 4,944 shares of INCY stock, worth $317,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,944
Previous 4,296 15.08%
Holding current value
$317,652
Previous $296,000 1.01%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 16, 2025

BUY
$60.0 - $75.26 $38,880 - $48,768
648 Added 15.08%
4,944 $299,000
Q4 2024

Feb 05, 2025

BUY
$65.08 - $83.38 $6,768 - $8,671
104 Added 2.48%
4,296 $296,000
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $88,058 - $105,384
1,536 Added 57.83%
4,192 $277,000
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $122,627 - $152,745
2,396 Added 921.54%
2,656 $161,000
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $14,703 - $17,313
260 New
260 $14,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.